Pharmaceutical Cause Marketing
Survey began 10 March 2004.
Survey Ended 28 May 2004.
An article in the March 10, 2004 issue of the Wall Street Journal entitled “Behind the “Boomer Coalition,” a Heart Message from Pfizer” (subscription required) characterized pharmaceutical funding of disease awareness programs “cause marketing.”
- Some people may be confused by the term “cause marketing” as used in this article. Have you heard the term “cause marketing” used in the context of pharmaceutical marketing before?
- Do you think that this program will help Pfizer directly or indirectly improve customer relations?
- The FDA, in recent guidance to the pharma industry, suggested that pharmaceutical companies can play an important educational role in disease awareness.
- According to the article, Pfizer provided financial support to the Boomer Coalition and has two people on its advisory board (a medical person and a marketing person). Do you believe that such an organization can be unbiased?
- Will the aging boomer population be a boon to the pharmaceutical industry (e.g., spurring the development of new products and/or significantly increasing pharma profits)?
- Interactive Summary of ALL results (de-identified, excludes open-ended responses and comments that may identify the respondent). Allows you to use filters to examine results from different subsets of respondents (e.g., pharma company employees vs. non-pharma people, etc.)
Associated article(s) touching on this topic: